Article Details

Cholangiocarcinoma Foundation congratulates AstraZeneca TOPAZ-1, the first Phase III trial ...

Retrieved on: 2022-01-22 14:27:58

Tags for this article:

Click the tags to see associated articles and topics

Cholangiocarcinoma Foundation congratulates AstraZeneca TOPAZ-1, the first Phase III trial .... View article details on hiswai:

Excerpt

On behalf of patients and families impacted by cholangiocarcinoma (bile duct cancer), the Cholangiocarcinoma Foundation congratulates AstraZeneca ...

Article found on: outbreaknewstoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up